Home | Welcome to Contract Pharma   
Last Updated Friday, October 31 2014
Print RSS Feed

Breaking News

Related Searches:
April 15, 2011
Pfizer achieved positive results from the ORAL Scan Phase III study of tofacitinib, an investigational oral JAK inhibitor, in patients with moderate-to-severe active rheumatoid arthritis (RA) who had an inadequate response to methotrexate (MTX).  Read More »
April 15, 2011
Galapagos NV will discontinue its Phase II trial for GLPG0259 in rheumatoid arthritis (RA) following a planned interim analysis that did not support continuing development of the drug for RA.   Read More »
April 15, 2011
Remicade, Simponi rights in several regions go to J&J, along with cash and profit-split  Read More »
April 14, 2011
The Ortho-McNeil Neurologics Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. (itself a division of Johnson & Johnson) is voluntarily recalling two lots of Topamax (topiramate) 100mg Tablets, shipped between 10/19/2010 and 12/28/2010, and distribute  Read More »
April 14, 2011
Pharmaceuticals Division sales were down 2% in the quarter.   Read More »
April 14, 2011
Axcan has entered into an agreement to acquire Mpex Pharmaceuticals, Inc. and its lead product candidate, Aeroquin, a new aerosol formulation of levofloxacin.   Read More »
April 14, 2011
Watson Pharmaceuticals, Inc. has formally designated its Parsippany, NJ facility as its new corporate headquarters.   Read More »
April 13, 2011
West Pharmaceutical Services, Inc. is adding manufacturing capacity for the Daikyo Crystal Zenith 1mL syringe system for biopharmaceutical drug packaging and delivery.  Read More »
April 13, 2011
Amunix, Inc. has entered into an exclusive worldwide research collaboration with Biogen Idec to research and develop novel, fully-recombinant blood factors (Factors IX, VIII and VIIa) with improved therapeutic properties.  Read More »
April 13, 2011
Dimerix Bioscience Pty Ltd. has entered into a second research program with Takeda Cambridge Ltd., a UK based subsidiary of Takeda Pharmaceutical Co.  Read More »
April 13, 2011
Access Pharmaceuticals, Inc. has entered into an agreement with a major pharmaceutical company to use its CobaCyte and CobOral technology for the targeted delivery of RNAi therapeutics.   Read More »
April 12, 2011
Pieris AG has entered into a collaboration and license agreement with Daiichi Sankyo Co. Ltd., under which Pieris will apply its Anticalin scaffold technology to discover novel Anticalins against two Daiichi Sankyo targets.   Read More »
April 12, 2011
Novartis AG is discontinuing development of Tasigna as a treatment for cancerous tumors of the gastrointestinal tract.  Read More »
April 12, 2011
NSF-DBA has added five pharmaceutical experts to provide consulting and in-house training services to help companies comply with international regulations and improve quality management systems.  Read More »
April 12, 2011
Orasi Medical has entered into an agreement with Biogen Idec to test novel biomarkers for the development of treatments for central nervous system (CNS) disorders.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On